About Dolvis Bio Pharma Private Limited
Data last updated:
Dolvis Bio Pharma Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC033674. Its GSTIN is 04AAECD2104M1Z1 (Chandigarh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Piyush Garg and Sanjay Kumar Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.57 Cr. For the same year it recorded a net profit of ₹35.08 Lakh (net margin 2.8%) and EBITDA of ₹56.34 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹65 Lakh and satisfied charges of ₹70 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dolvisbiopharma.in.
Company details
Contact details
Dolvis Bio Pharma Private Limited's registered office is in Manimajra, Chandigarh. Its website is dolvisbiopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dolvis Bio Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dolvis Bio Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dolvis Bio Pharma Private Limited, buy the company report.
Financials of Dolvis Bio Pharma Private Limited
FY 2025 filings availableDolvis Bio Pharma Private Limited reported revenue of ₹12.57 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dolvis Bio Pharma Private Limited, buy the company report.
Board of directors of Dolvis Bio Pharma Private Limited
Dolvis Bio Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Garg | Director | 01 Feb 2025 | 1 Years 8 Months | Current |
| Sanjay Kumar Garg Also directs: Oasis Bio Bloom LLP, Aingo Pharma Private Limited, Vlead Labs Private Limited and 4 more | Director | 27 Mar 2012 | 14 Years 6 Months | Current |
Peer comparison
Dolvis Bio Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vitara Cure Private Limited | ₹12.66 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Bansal Pharmachem Pvt. Ltd. | ₹12.62 Cr (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Paradigm Medivision Private Limited | ₹12.61 Cr (FY 2019) | -21.0% | Hyderabad, Telangana, India | |||
| Elisa Biotech Private Limited | ₹12.59 Cr (FY 2025) | 17.0% | Delhi, India | |||
| Dolvis Bio Pharma Private Limitedthis company | ₹12.57 Cr (FY 2024) | ₹35.08 Lakh | 2.8% | Manimajra, Chandigarh, India | ||
| Saamag Healthcare Professional Management Private Limited | ₹12.57 Cr (FY 2022) | -71.0% | New Delhi, Delhi, India | |||
| Health Medivision Private Limited | ₹12.56 Cr (FY 2024) | -1.0% | Delhi, India | |||
| Regain Lifecare Limited | ₹12.53 Cr (FY 2024) | 40.0% | Hisar, Haryana, India |
To see the full peer comparison of Dolvis Bio Pharma Private Limited, buy the company report.
Auditor
Dolvis Bio Pharma Private Limited is audited by SHIV BANSAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIV BANSAL & CO | FY 2023 | 021339N |
Shareholding
The shareholding of Dolvis Bio Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dolvis Bio Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2024 | 100964094 | Others | ₹15 Lakh | Open | |
| 29 Mar 2024 | 100889221 | Others | ₹50 Lakh | Open | |
| 06 Aug 2015 | 10603533 | Hdfc Bank Limited | ₹70 Lakh | Satisfied |
To see the full charge records of Dolvis Bio Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Dolvis Bio Pharma Private Limited has 3 court cases on record: 3 filed by Dolvis Bio Pharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Sagar Medipharma Pvt Ltd. and 3 others | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Ascent Pharma and 1 other | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S GVR Pharma Distributors and 1 other | Disposed |
To see the full case history of Dolvis Bio Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dolvis Bio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dolvis Bio Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECD2104M1Z1 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dolvis Bio Pharma Private Limited, buy the company report.
Recent activity
Dolvis Bio Pharma Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Piyush Garg ceased to be Additional Director on 29 Sep 2025.
1 earlier event is in the company report.
Frequently asked questions
Dolvis Bio Pharma is an active private limited company based in Manimajra, Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 March 2012 (14+ years old) and is registered under CIN U24232CH2012PTC033674.
Dolvis Bio Pharma has 2 current directors:
- Piyush Garg - Director
- Sanjay Kumar Garg - Director
The latest financial statements of Dolvis Bio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dolvis Bio Pharma is 04AAECD2104M1Z1, registered in Chandigarh.
The CIN (Corporate Identification Number) of Dolvis Bio Pharma is U24232CH2012PTC033674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dolvis Bio Pharma has 3 court cases on record: 3 filed by the company.
Dolvis Bio Pharma was incorporated on 27 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Dolvis Bio Pharma by revenue are Vitara Cure Private Limited, Bansal Pharmachem Pvt. Ltd, Paradigm Medivision Private Limited, Elisa Biotech Private Limited, Saamag Healthcare Professional Management Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Piyush Garg ceased to be Additional Director on 29 Sep 2025. Piyush Garg was appointed as Director on 01 Feb 2025. Anita Garg ceased to be Additional Director on 30 Sep 2019. Dolvis Bio Pharma has 5 board changes on record in total.
Dolvis Bio Pharma can be reached through the website dolvisbiopharma.in. Its registered office is in Manimajra, Chandigarh, India.
The registered office of Dolvis Bio Pharma is at Scf 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.